BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36368252)

  • 1. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
    Panje C; Hayoz S; Eisterer W; Hess V; Thuss-Patience P; Schacher S; Dürr D; Wagner AD; Girschikofsky M; Eboulet E; Stahl M; Ruhstaller T
    Eur J Cancer; 2022 Dec; 177():186-193. PubMed ID: 36368252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
    Pape M; Vissers PAJ; Bertwistle D; McDonald L; Beerepoot LV; van Berge Henegouwen MI; Lagarde SM; Mook S; Mohammad NH; Jeene PM; van Laarhoven HWM; Verhoeven RHA
    Br J Surg; 2022 Nov; 109(12):1264-1273. PubMed ID: 35998093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
    Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ;
    Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
    Hsu PK; Chien LI; Wang LC; Chou TY;
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
    Wang Y; Zhu L; Xia W; Wu L; Wang F
    World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
    Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in recurrent esophageal or junctional cancer.
    Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
    Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognostic factors in patients with locoregional recurrence of esophageal carcinoma after curative treatment].
    Xu YP; Mao WM; Ma SL; Jiang YH; Liu JS; Sun XJ
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):925-8. PubMed ID: 22340103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma.
    Hsu PK; Chen HS; Huang CS; Liu CC; Hsieh CC; Hsu HS; Wu YC; Wu SC
    Br J Surg; 2017 Jan; 104(1):90-97. PubMed ID: 27859017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
    Noordman BJ; Spaander MCW; Valkema R; Wijnhoven BPL; van Berge Henegouwen MI; Shapiro J; Biermann K; van der Gaast A; van Hillegersberg R; Hulshof MCCM; Krishnadath KK; Lagarde SM; Nieuwenhuijzen GAP; Oostenbrug LE; Siersema PD; Schoon EJ; Sosef MN; Steyerberg EW; van Lanschot JJB;
    Lancet Oncol; 2018 Jul; 19(7):965-974. PubMed ID: 29861116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.
    Saigí M; Oliva M; Aliste L; Calvo M; Hormigo G; Serra Ò; Boladeras A; Farran L; Robles J; Creus G; Paúles MJ; Gornals JB; de Lama E; Borràs JM; Sala N; Galán M
    PLoS One; 2017; 12(9):e0184737. PubMed ID: 28931046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.
    Zhou N; Mitchell KG; Corsini EM; Truong VTT; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Ajani JA; Hofstetter WL
    Br J Surg; 2021 Oct; 108(10):1207-1215. PubMed ID: 34095952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.
    Koizumi W; Kitago M; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Inomata K; Kawakubo H; Kawaida M; Kitagawa Y
    BMC Cancer; 2019 Apr; 19(1):320. PubMed ID: 30953505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
    van der Woude SO; Hulshof MC; van Laarhoven HW
    Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.